Cargando…

Biologic Treatment Algorithms for Moderate-to-Severe Psoriasis with Comorbid Conditions and Special Populations: A Review

The emergence of data from clinical trials of biologics, the approval of new biologics, and our improved understanding of psoriasis pathogenesis have increased the therapeutic possibilities for the treatment of moderate-to-severe psoriasis. Biologics currently approved for the treatment of psoriasis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thatiparthi, Akshitha, Martin, Amylee, Liu, Jeffrey, Egeberg, Alexander, Wu, Jashin J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Current Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051287/ https://www.ncbi.nlm.nih.gov/pubmed/33861409 http://dx.doi.org/10.1007/s40257-021-00603-w

Ejemplares similares

The risk of COVID-19 in patients with psoriasis: A retrospective cohort study
por: Wu, Jashin J., et al.
Publicado: (2022)

Effect Modification by Smoking Status on the Association Between Psoriasis and Chronic Obstructive Pulmonary Disease among Adults in the USA
por: LIU, Jeffrey, et al.
Publicado: (2021)

A response to “Male balding is a major risk factor for severe COVID-19”
por: Thatiparthi, Akshitha, et al.
Publicado: (2021)

The risk of COVID-19 infection in patients with atopic dermatitis: A retrospective cohort study
por: Wu, Jashin J., et al.
Publicado: (2022)

Preliminary outcomes of 2020-2021 dermatology residency application cycle and adverse effects of COVID-19
por: Thatiparthi, Akshitha, et al.
Publicado: (2021)

Expert Perspectives on Key Parameters that Impact Interpretation of Randomized Clinical Trials in Moderate-to-Severe Atopic Dermatitis
por: Silverberg, Jonathan I., et al.
Publicado: (2021)

Pharmacological Management of Borderline Personality Disorder and Common Comorbidities
por: Pascual, Juan C., et al.
Publicado: (2023)

Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
por: Jiang, Yuxiong, et al.
Publicado: (2023)

Nail Psoriasis and Quality-of-Life Measurement in Clinical Trials: Call for the Use of Nail-Specific Instruments
por: Blome, Christine, et al.
Publicado: (2021)

Mpox and Monkeypox Virus: Special Considerations for Athletes in Contact Sports
por: Smoliga, James M.
Publicado: (2023)

Specialization in acute care surgery in low-income and middle-income countries
por: Yi, Sojung, et al.
Publicado: (2017)

Metabolic Comorbidities and Cardiovascular Disease in Pediatric Psoriasis: A Narrative Review
por: Marani, Andrea, et al.
Publicado: (2022)

Simplified treatment algorithm for the management of trauma-induced hemorrhage without viscoelastic testing
por: Casu, Sebastian
Publicado: (2021)

Physiologically Based Pharmacokinetic (PBPK) Model-Informed Dosing Guidelines for Pediatric Clinical Care: A Pragmatic Approach for a Special Population
por: Freriksen, Jolien J. M., et al.
Publicado: (2022)

Comorbidities in Chilean patients with psoriasis: a Global Healthcare Study on Psoriasis
por: Valenzuela, Fernando, et al.
Publicado: (2022)

Comparability Considerations and Challenges for Expedited Development Programs for Biological Products
por: Schrieber, Sarah J., et al.
Publicado: (2020)

Comparability of Biologics: Global Principles, Evidentiary Consistency and Unrealized Reliance
por: Webster, Christopher J., et al.
Publicado: (2021)

Predictors of Response to Biologics in Patients with Moderate-to-severe Psoriasis: A Danish Nationwide Cohort Study
por: SCHWARZ, Christopher Willy, et al.
Publicado: (2021)

Pharmaceutical, Biological, and Clinical Properties of Botulinum Neurotoxin Type A Products
por: Frevert, Jürgen
Publicado: (2015)

Development of New Formulations of Biologics: Expectations, Immunogenicity, and Safety for Subcutaneous Trastuzumab
por: Pimentel, Franklin Fernandes, et al.
Publicado: (2018)

Interchangeability for Biologics is a Legal Distinction in the USA, Not a Clinical One
por: Park, Joseph P., et al.
Publicado: (2022)

Time to Differentiate Postactivation “Potentiation” from “Performance Enhancement” in the Strength and Conditioning Community
por: Prieske, Olaf, et al.
Publicado: (2020)

Should Heartbeats/Training Session Be Considered When Comparing the Cardiovascular Benefits of High-Intensity Interval Aerobic and Moderate-Intensity Continuous Training? A Critical Appraisal
por: Rodrigues, Jhennyfer Aline Lima, et al.
Publicado: (2020)

Insulins as Drugs or Biologics in the USA: What Difference Does it Make and Why Does it Matter?
por: George, Kelly, et al.
Publicado: (2019)

Optimizing the Dosing of Intravenous Theophylline in Acute Severe Asthma in Children
por: Saint, Gemma L., et al.
Publicado: (2018)

Management of Moderate to Severe Psoriasis in Patients with Metabolic Comorbidities
por: Gisondi, Paolo, et al.
Publicado: (2015)

Ensuring Product Quality, Consistency and Patient Supply over Time for a Large-Volume Biologic: Experience with Remicade(®)
por: Melsheimer, Richard, et al.
Publicado: (2018)

Egyptian Atherosclerosis and Vascular Biology Association Consensus on the Use of Sodium Glucose Cotransporter-2 Inhibitors in Heart Failure with Reduced Ejection Fraction
por: Elserafy, Ahmed S., et al.
Publicado: (2021)

Economic Burden of Comorbidities in Patients with Psoriasis in the USA
por: Wu, Jashin J., et al.
Publicado: (2022)

Cell Therapy of Severe Ischemia in People with Diabetic Foot Ulcers—Do We Have Enough Evidence?
por: Dubský, Michal, et al.
Publicado: (2023)

ESC Joint Working Groups on Cardiovascular Surgery and the Cellular Biology of the Heart Position Paper: Peri-operative myocardial injury and infarction in patients undergoing coronary artery bypass graft surgery
por: Thielmann, Matthias, et al.
Publicado: (2017)

Economic and Comorbidity Burden Among Patients with Moderate-to-Severe Psoriasis
por: Feldman, Steven R., et al.
Publicado: (2015)

Anti-Amyloid Monoclonal Antibodies are Transformative Treatments that Redefine Alzheimer's Disease Therapeutics
por: Cummings, Jeffrey
Publicado: (2023)

Economic and Comorbidity Burden Among Moderate‐to‐Severe Psoriasis Patients with Comorbid Psoriatic Arthritis
por: Feldman, Steven R., et al.
Publicado: (2015)

Rapid Response of Biologic Treatments of Moderate-to-Severe Plaque Psoriasis: A Comprehensive Investigation Using Bayesian and Frequentist Network Meta-analyses
por: Warren, Richard B., et al.
Publicado: (2019)

Clinical recommendations for high altitude exposure of individuals with pre-existing cardiovascular conditions: A joint statement by the European Society of Cardiology, the Council on Hypertension of the European Society of Cardiology, the European Society of Hypertension, the International Society of Mountain Medicine, the Italian Society of Hypertension and the Italian Society of Mountain Medicine
por: Parati, Gianfranco, et al.
Publicado: (2018)

Lofty goals and strategic plans are not enough to achieve and maintain a diverse workforce: an American Association for the Surgery of Trauma Diversity, Equity, and Inclusion Committee conversation
por: Brasel, Karen, et al.
Publicado: (2021)

Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence
por: Facente, Shelley N., et al.
Publicado: (2021)

Medicines Regulation in Africa: Current State and Opportunities
por: Ndomondo-Sigonda, Margareth, et al.
Publicado: (2017)

Developing Medical Affairs Leaders Who Create the Future
por: Bedenkov, Alexander, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6o0dgrda0t1o71nts1tcca6aa8